Key facts
- This page summarizes Amy Belt Raimundo's Form 4 filing for NUVASIVE INC.
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 05 Sep 2023, 17:04.
Amy Belt Raimundo - 01 Sep 2023 Form 4 Insider Report for NUVASIVE INC
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 01 Sep 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Sep 2023, 17:04:52 UTC
- Prior SEC filing
- 12 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nathaniel B. Sisitsky, Attorney-in-Fact for Amy Belt Raimundo
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Amy Belt Raimundo filed Form 4 for NUVASIVE INC on 05 Sep 2023.
Change
- Previous filing in this sequence was filed on 12 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NUVA
transaction
Derivative
Restricted Stock Uni
Disposed to Issuer
- Transaction value
- $0
- Shares
- -2,427
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 01 Sep 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,427
- Exercise price
- Footnotes
- F1, F2
NUVA
transaction
Derivative
Restricted Stock Uni
Disposed to Issuer
- Transaction value
- $0
- Shares
- -3,788
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 01 Sep 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,788
- Exercise price
- Footnotes
- F1, F2
NUVA
transaction
Derivative
Restricted Stock Uni
Disposed to Issuer
- Transaction value
- $0
- Shares
- -4,816
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 01 Sep 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,816
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Amy Belt Raimundo is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
Represented a contingent right to receive one share of the Issuer's common stock upon vesting.
Footnote F2
Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the "Merger Agreement"), by and among the Issuer, Globus Medical, Inc. ("Globus") and Zebra Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Globus, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of Issuer common stock underlying such award.